Boston, Massachusetts, United States The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Boston.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Momenta Pharmaceuticals, MacroGenics. The fund has no exact preference in some founders of portfolio startups.
The average startup value when the investment from Mithra Ventures is 50-100 millions dollars. Opposing the other organizations, this Mithra Ventures works on 38 percentage points more the average amount of lead investments. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2004. The increased amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Mithra Ventures, startups are often financed by TPG, Red Abbey Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are TPG, Red Abbey Venture Partners, OrbiMed. In the next rounds fund is usually obtained by TPG, InterWest Partners, Alta Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Asiantrust Capital Partners | Central, Central Region, Singapore |
| Endemol | England, London, United Kingdom |
| Envision Capital | China, Shanghai |
| Fenghua Capital | China, Hangzhou, Zhejiang |
| Futian Investment Holdings | China, Guangdong, Shenzhen |
| Hainan Yongwang Touzi | China, Hainan, Hainan Province |
| Interswitch | Lagos, Lagos, Nigeria |
| Ningbo Meishan Baoshui Gangqu Chenhui Touzi Hehuo Qiye | China, Ningbo, Zhejiang |
| Northern Ontario Heritage Fund | Canada, Ontario, Sault Sainte Marie |
| Scale Lab Andorra | Andorra, Aragon, Spain |
| Singtel Innov8 | Central Region, Singapore, Singapore |
| Skullcandy | Park City, United States, Utah |
| The Origin Capital | Central, Central Region, Singapore |
| Wachstumsfonds Bayern | Bayern, Germany, München |
| Xiaoshi Ziben | - |
| Yonghui Yingtai Zichan | China, Jiaxing, Zhejiang |
| Zuig Investment | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MacroGenics | $45M | 17 May 2006 | Maryland, United States | ||
MacroGenics | $30M | 15 Oct 2004 | Maryland, United States | ||
Momenta Pharmaceuticals | $20M | 02 Mar 2004 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MacroGenics | $45M | 17 May 2006 | Maryland, United States | ||
MacroGenics | $30M | 15 Oct 2004 | Maryland, United States | ||
Momenta Pharmaceuticals | $20M | 02 Mar 2004 | - |
